Preventable Deaths among HIV-Positive Patients: A Real-Life Perspective from a Teaching Hospital in Northern Mexico
Journal Title: HIV/AIDS Research and Treatment – Open Journal - Year 2018, Vol 5, Issue 1
Abstract
Introduction Antiretroviral therapy (ART) in patients infected with human immunodeficiency virus (HIV) are more effective and better tolerated and for this reason the gap between life expectancy of an HIV-seropositive individual and a seronegative one has been closing. This study was carried out to identify the main causes of death in in HIV-infected patients in a tertiary-care hospital as well as relevant sociodemographic and clinical factors that contribute to their prognosis. Aim The aim of the present study is to identify the main causes of death in HIV/AIDS patients as well as relevant sociodemographic and clinical factors that contribute to their prognosis. Methods A retrospective cohort was conducted with confirmed HIV-infected adult patients who died between January 2010 and January 2017. Sociodemographic and clinical data were taken from their clinical records to carry out a statistical analysis on the mortality of these patients and the relevant factors that contributed. Results A total of 120 patients with in-hospital mortality and HIV diagnosis were included, of these, 55% were allocated to an AIDS defining event, 75.8% had an HIV diagnosis of less than 6 months from their death, 88.3% received HIV testing for suspicion or confirmation of an AIDS defining event, and 50% had two or more active AIDS defining events at admission. Conclusion A major public health concern is a late HIV/AIDS diagnosis, a situation that is occurring in Mexico. Despite universal access to antiretroviral treatment, the most common causes of mortality in HIV-positive patients are still AIDS defining events, mainly tuberculosis and other opportunistic infections that with a prompt diagnosis might have been prevented if these patients had initiated early antiretroviral therapy.
Authors and Affiliations
Adrián Camacho-Ortiz
Keywords
Related Articles
- EP ID EP555410
- DOI 10.17140/HARTOJ-5-128
- Views 129
- Downloads 0
World AIDS Day: A Call to Action
December 1st is World AIDS Day (WAD); a time to raise awareness about the Human Immunodeficiency Virus (HIV) and Acquired Immune Deficiency Syndrome (AIDS) and reflect on the lives of those living with and affected by th...
Cerebral Toxoplasmosis in a Treatment Naive HIV Patient with High CD4 Count Responding to Treatment with a Regime of Cotrimoxazole and Pyrimethamine: DoWe Need to Start Prophylaxis for Toxoplasmosis at a Higher CD4 Count?
Cerebral toxoplasmosis is one of the commonest opportunistic infection of the nervous system in HIV patients. We present a case of gradual onset haemiparesis in an ART naïve HIV patient with high CD4 count who was subseq...
A Rare Case of BCGiosis With Severe Combined Immunodeficiency
Background: Bacille Calmette-Guerin (BCG), a live attenuated vaccine, is safe and given to all neonates in endemic countries; however may rarely cause disseminated disease, especially in immuno-deficient individuals. Cas...
Prevalence of Hepatitis B Virus among Blood Donors and Assessment of Blood Donor’s Knowledge about HBV in Sudan
The prevalence of Hepatitis B varies between different regions of Sudan according to several published reports, but no data is available about the prevalence of HBV in all Sudan states, in a given time. The objective of...
Religious and Psychosocial Covariates of Health-Related Quality of Life in People Living with HIV/AIDS
HIV/AIDS is a chronic, highly stigmatized illness that requires significant lifestyle adjustments, including consistent adherence to Antiretroviral Therapy (ART) in order for People Living With HIV/AIDS (PLWH) to survive...